Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7178-7188

  Koma, Takaaki ^a,c   Yoshimatsu, Kumiko ^a   Nagata, Noriyo ^b   Sato, Yuko ^b   Shimizu, Kenta ^a   Yasuda, Shumpei P ^a   Amada, Takako ^a   Nishio, Sanae ^a   Hasegawa, Hideki ^b   Arikawa, Jiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HANTAVIRUS INFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE COUNT; LUNG EDEMA; LYMPHOCYTE DEPLETION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY VASCULAR HYPERPERMEABILITY; SCID MOUSE; VASCULAR DISEASE; VIRUS LOAD; VIRUS STRAIN; ANIMAL; B LYMPHOCYTE; CAPILLARY PERMEABILITY; CELL CULTURE; COMPLICATION; DISEASE MODEL; ENZYME IMMUNOASSAY; GENETICS; HANTAVIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; METABOLISM; PATHOGENICITY; PATHOLOGY; PULMONARY EDEMA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIROLOGY; WESTERN BLOTTING;

MESSENGER RNA;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; MICE; MICE, SCID; NEUTROPHILS; PULMONARY EDEMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84901992357     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00254-14     Document Type: Article

References (74)

1. Plyusnin A, Vapalahti O, Vaheri A. 1996. Hantaviruses: genome structure, expression and evolution. J. Gen. Virol. 77:2677-2687. http://dx.doi .org/10.1099/0022-1317-77-11-2677.
2. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917. http://dx.doi.org/10.1126/science .8235615.
3. Lee HW, Lee PW, Johnson KM. 1978. Isolation of the etiologic agent of Korean Hemorrhagic fever. J. Infect. Dis. 137:298-308. http://dx.doi.org /10.1093/infdis/137.3.298.
4. Lee HW, van der Groen G. 1989. Hemorrhagic fever with renal syndrome. Prog. Med. Virol. 36:62-102.
5. Lee HW. 1982. Korean hemorrhagic fever. Prog. Med. Virol. 28:96-113.
6. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. 2003. Hantavirus infections in Europe. Lancet Infect. Dis. 3:653-661. http://dx.doi.org/10.1016/S1473-3099(03)00774-6.
7. Muranyi W, Bahr U, Zeier M, van der Woude FJ. 2005. Hantavirus infection. J. Am. Soc. Nephrol. 16:3669-3679. http://dx.doi.org/10.1681 /ASN.2005050561.
8. Plyusnin A, Kruger DH, Lundkvist A. 2001. Hantavirus infections in Europe. Adv. Virus Res. 57:105-136. http://dx.doi.org/10.1016/S0065-3527(01)57002-5.
9. Enria DA, Briggiler AM, Pini N, Levis S. 2001. Clinical manifestations of New World hantaviruses. Curr. Top. Microbiol. Immunol. 256:117-134.
10. Jonsson CB, Figueiredo LT, Vapalahti O. 2010. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23: 412-441. http://dx.doi.org/10.1128/CMR.00062-09.
11. Tsergouli K, Papa A. 2013. Vascular endothelial growth factor levels in Dobrava/Belgrade virus infections. Viruses 5:3109-3118. http://dx.doi .org/10.3390/v5123109.
12. Kim D. 1965. Clinical analysis of 111 fatal cases of epidemic hemorrhagic fever. Am. J. Med. 39:218-220. http://dx.doi.org/10.1016/0002-9343 (65)90044-6.
13. Steer A. 1955. Pathology of hemorrhagic fever: a comparison of the findings; 1951 and 1952. Am. J. Pathol. 31:201-221.
14. Clement J, Colson P, McKenna P. 1994. Hantavirus pulmonary syndrome in New England and Europe. N. Engl. J. Med. 331:545-548. http: //dx.doi.org/10.1056/NEJM199408253310813.
15. Lukes RJ. 1954. The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am. J. Med. 16:639-650. http://dx.doi.org/10.1016/0002-9343(54)90270-3.
16. Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C.2011. Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur. J. Clin. Microbiol. Infect. Dis. 30:685-690.
17. Nguyen AT, Penalba C, Bernadac P, Jaafar S, Kessler M, Canton P, Hoen B. 2001. Respiratory manifestations of hemorrhagic fever with renal syndrome: retrospective study of 129 cases in Champagne-Ardenne and Lorraine. Presse Med. 30:55-58. (In French.).
18. Seitsonen E, Hynninen M, Kolho E, Kallio-Kokko H, Pettila V. 2006. Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 25:261-266. http://dx .doi.org/10.1007/s10096-006-0117-z.
19. Hjelle B, Jenison SA, Goade DE, Green WB, Feddersen RM, Scott AA. 1995. Hantaviruses: clinical, microbiologic, and epidemiologic aspects. Crit. Rev. Clin. Lab. Sci. 32:469-508. http://dx.doi.org/10 .3109/10408369509082592.
20. Hjelle B, Goade D, Torrez-Martinez N, Lang-Williams M, Kim J, Harris RL, Rawlings JA. 1996. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin. Infect. Dis. 23:495-500. http://dx.doi.org/10.1093/clinids/23.3.495.
21. Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE. 2009. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am. J. Trop. Med. Hyg. 80:279-285.
22. Lahdevirta J. 1982. Clinical features of HFRS in Scandinavia as compared with East Asia. Scand. J. Infect. Dis. Suppl. 36:93-95.
23. Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J. 1992. Hantaan virus infection of human endothelial cells. J. Virol. 66:5929-5936.
24. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, Merlin TL, McFeeley PJ, Umland ET, Zumwalt RE. 1995. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26:110-120. http://dx.doi .org/10.1016/0046-8177(95)90123-X.
25. Yanagihara R, Silverman DJ. 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 111:281-286. http://dx.doi.org/10.1007/BF01311063.
26. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE, Ksiazek TG, Nichol ST, Mahy BWJ, Peters CJ. 1995. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.
27. Koster F, Foucar K, Hjelle B, Scott A, Chong YY, Larson R, McCabe M.2001. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am. J. Clin. Pathol. 116:665-672. http://dx.doi.org/10.1309/CNWF-DC72-QYMR-M8DA.
28. Huang C, Jin B, Wang M, Li E, Sun C. 1994. Hemorrhagic fever with renal syndrome: relationship between pathogenesis and cellular immunity. J. Infect. Dis. 169:868-870. http://dx.doi.org/10.1093/infdis/169.4 .868.
29. Markotic A, Dasic G, Gagro A, Sabioncello A, Rabatic S, Kuzman I, Zgorelec R, Smoljan I, Beus I, Zupanc TA, Dekaris D. 1999. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin. Exp. Immunol. 115:329-334. http://dx.doi.org/10.1046/j.1365-2249 .1999.00790.x.
30. Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H. 1996. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin. Immunol. Immunopathol. 78:47-55. http://dx.doi.org/10.1006/clin.1996 .0007.
31. Krakauer T, Leduc JW, Krakauer H. 1995. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome. Viral Immunol. 8:75-79. http://dx.doi.org/10.1089 /vim.1995.8.75.
32. Krakauer T, Leduc JW, Morrill JC, Anderson AO, Krakauer H. 1994. Serum levels of alpha and gamma interferons in hemorrhagic fever with renal syndrome. Viral Immunol. 7:97-101. http://dx.doi.org/10.1089/vim .1994.7.97.
33. Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A. 1996. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173:38-43. http://dx.doi.org/10.1093 /infdis/173.1.38.
34. Makela S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A. 2004. Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am. J. Kidney Dis. 43:809-816. http://dx.doi.org/10.1053/j.ajkd.2003.12.044.
35. Pal E, Strle F, Avsic-Zupanc T. 2005. Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia: an 18-year survey. Wien Klin. Wochenschr. 117:398-405. http://dx.doi.org/10.1007/s00508-005-0359-2.
36. Hjelle B, Jenison S, Mertz G, Koster F, Foucar K. 1994. Emergence of hantaviral disease in the southwestern United States. West. J. Med. 161: 467-473.
37. Mir MA. 2010. Hantaviruses. Clin. Lab. Med. 30:67-91. http://dx.doi.org /10.1016/j.cll.2010.01.004.
38. Lilius EM, Nuutila J. 2012. Bacterial infections, DNA virus infections, and RNA virus infections manifest differently in neutrophil receptor expression. Sci. World J. 2012:527347. http://dx.doi.org/10.1100/2012 /527347.
39. Dale DC. 2010. Neutropenia and neutrophilia, p 939-950. In Kaushansky K, Beutler E, Seligsohn U, Lichtman MA, Kipps TJ, Prchal J (ed), Williams hematology, 8th ed. McGraw-Hill Book Co, Inc, New York, NY.
40. Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Nichol S, Spiropoulou C, Morzunov S, Feldmann H, Sanchez A, Khan AS, Mahy BWJ, Wachsmuth K, Butler JC. 1995. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am. J. Trop. Med. Hyg. 52:117-123.
41. Abraham E. 2003. Neutrophils and acute lung injury. Crit. Care Med. 31:S195-S199. http://dx.doi.org/10.1097/01.CCM.0000057843.47705.E8.
42. Taichman NS, Young S, Cruchley AT, Taylor P, Paleolog E. 1997. Human neutrophils secrete vascular endothelial growth factor. J. Leukoc. Biol. 62:397-400.
43. Mantovani A, Cassatella MA, Costantini C, Jaillon S. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:519-531. http://dx.doi.org/10.1038/nri3024.
44. Gueders MM, Foidart JM, Noel A, Cataldo DD. 2006. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur. J. Pharmacol. 533:133-144. http://dx.doi.org/10.1016/j.ejphar.2005.12.082.
45. Tapper H, Karlsson A, Morgelin M, Flodgaard H, Herwald H. 2002. Secretion of heparin-binding protein from human neutrophils is deter-mined by its localization in azurophilic granules and secretory vesicles. Blood 99:1785-1793. http://dx.doi.org/10.1182/blood.V99.5.1785.
46. DiStasi MR, Ley K. 2009. Opening the flood-gates: how neutrophilendothelial interactions regulate permeability. Trends Immunol. 30:547-556. http://dx.doi.org/10.1016/j.it.2009.07.012.
47. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6-14. http://dx.doi.org/10.1006/viro.2001.1133.
48. Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, Larsen T, Hooper JW. 2007. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J. Virol. 81:7449-7462. http://dx.doi .org/10.1128/JVI.00238-07.
49. Chu YK, Jennings GB, Schmaljohn CS. 1995. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 69:6417-6423.
50. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. 1990. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:3162-3170.
51. + T-cell responses in mice infected with Hantaan virus. Arch. Virol. 149:1373-1382. http://dx.doi.org/10.1007/s00705-003-0285-4.
52. Seto T, Nagata N, Yoshikawa K, Ichii O, Sanada T, Saasa N, Ozaki Y, Kon Y, Yoshii K, Takashima I, Kariwa H. 2011. Infection of Hantaan virus strain AA57 leading to pulmonary disease in laboratory mice. Virus Res. 163:284-290. http://dx.doi.org/10.1016/j.virusres.2011.10.016.
53. Tamura M, Asada H, Kondo K, Tanishita O, Kurata T, Yamanishi K.1989. Pathogenesis of Hantaan virus in mice. J. Gen. Virol. 70(Pt 11): 2897-2906. http://dx.doi.org/10.1099/0022-1317-70-11-2897.
54. Yoshimatsu K, Arikawa J, Tamura M, Yoshida R, Lundkvist A, Niklasson B, Kariwa H, Azuma I. 1996. Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies. J. Gen. Virol. 77(Pt 4):695-704. http://dx.doi.org/10.1099/0022-1317-77-4-695.
55. Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen H, Hancock RE. 2010. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 184:2539-2550. http://dx.doi.org/10.4049/jimmunol .0901813.
56. Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661-668. http://dx.doi.org/10.1084/jem.191.4.661.
57. Chaturvedi UC, Dhawan R, Khanna M, Mathur A. 1991. Breakdown of the blood-brain barrier during dengue virus infection of mice. J. Gen. Virol. 72(Pt 4):859-866.
58. Lacy P, Eitzen G. 2008. Control of granule exocytosis in neutrophils. Front. Biosci. 13:5559-5570. http://dx.doi.org/10.2741/3099.
59. Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. 2010. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 84:11227-11234. http://dx.doi.org/10.1128/JVI.01405-10.
60. Gavrilovskaya I, Gorbunova E, Koster F, Mackow E. 2012. Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012:674360. http: //dx.doi.org/10.1155/2012/674360.
61. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. 1995. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375:577-581. http://dx.doi.org/10.1038/375577a0.
62. Pham I, Uchida T, Planes C, Ware LB, Kaner R, Matthay MA, Clerici C. 2002. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L1133-L1142.
63. Tang N, Wang L, Esko J, Giordano FJ, Huang Y, Gerber HP, Ferrara N, Johnson RS. 2004. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6:485-495. http://dx.doi.org/10.1016/j.ccr.2004.09.026.
64. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA. 1999. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 179:295-302. http://dx.doi.org/10.1086/314597.
65. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA.2004. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172:3297-3304.
66. Ennis FA, Cruz J, Spiropoulou CF, Waite D, Peters CJ, Nichol ST, Kariwa H, Koster FT. 1997. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238:380-390. http://dx.doi.org/10.1006/viro.1997.8827.
67. Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, Saggioro FP, Figueiredo LT. 2006. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect. 8:2324-2330. http: //dx.doi.org/10.1016/j.micinf.2006.04.019.
68. Tuuminen T, Kekalainen E, Makela S, Ala-Houhala I, Ennis FA, Hedman K, Mustonen J, Vaheri A, Arstila TP. 2007. Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J. Immunol. 179:1988-1995.
69. Terajima M, Hayasaka D, Maeda K, Ennis FA. 2007. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol. Lett. 113:117-120. http://dx.doi.org/10.1016/j .imlet.2007.08.003.
70. Rasmuson J, Pourazar J, Linderholm M, Sandstrom T, Blomberg A, Ahlm C. 2011. Presence of activated airway T lymphocytes in human Puumala hantavirus disease. Chest 140:715-722. http://dx.doi.org/10 .1378/chest.10-2791.
71. Yoshimatsu K, Arikawa J, Ohbora S, Itakura C. 1997. Hantavirus infection in SCID mice. J. Vet. Med. Sci. 59:863-868. http://dx.doi.org/10.1292 /jvms.59.863.
72. Hammerbeck CD, Hooper JW. 2011. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J. Virol. 85:9929-9944. http://dx.doi.org/10.1128/JVI.05356-11.
73. Prescott J, Safronetz D, Haddock E, Robertson S, Scott D, Feldmann H.2013. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster. Immunology 140:168-178. http: //dx.doi.org/10.1111/imm.12116.
74. Brocato RL, Hammerbeck CD, Bell TM, Wells JB, Queen LA, Hooper JW. 2014. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus. J. Virol. 88:811-819. http://dx.doi.org/10.1128/JVI.02906-13.